|
Originally published In Press as doi:10.1074/jbc.M206184200 on August 9, 2002
J. Biol. Chem., Vol. 277, Issue 41, 38476-38485, October 11, 2002
A Role for G1/S Cyclin-dependent Protein
Kinases in the Apoptotic Response to Ionizing Radiation*
Carla V.
Finkielstein ,
Lin G.
Chen, and
James L.
Maller§
From the Howard Hughes Medical Institute and Department of
Pharmacology, University of Colorado School of Medicine,
Denver, Colorado 80262
In Xenopus development the
mid-blastula transition (MBT) marks a dramatic change in response of
the embryo to ionizing radiation. Whereas inhibition of cyclin D1-Cdk4
and cyclin A2-Cdk2 by p27Xic1 has been linked to cell cycle
arrest and prevention of apoptosis in embryos irradiated post-MBT,
distinct roles for these complexes during apoptosis are evident in
embryos irradiated pre-MBT. Cyclin A2 is cleaved by caspases to
generate a truncated complex termed N-cyclin A2-Cdk2, which is
kinase active, not inhibited by p27Xic1, and not sensitive
to degradation by the ubiquitin-mediated proteasome pathway. Moreover,
N-cyclin A2-Cdk2 has an expanded substrate specificity and can
phosphorylate histone H2B at Ser-32, which may facilitate DNA cleavage.
Consistent with a role for cyclin A2 in apoptosis, the addition of
N-cyclin A2-Cdk2, but not full-length cyclin A2-Cdk2, to
Xenopus egg extracts triggers apoptotic DNA fragmentation
even when caspases are not activated. Similarly, cyclin D1 is targeted
by caspases, and the generated product exhibits higher affinity for
p27Xic1, leading to reduced phosphorylation of the
retinoblastoma protein (pRB) during apoptosis. These data suggest that
caspase cleavage of both cyclin D1-Cdk4 and cyclin A2-Cdk2 promotes
specific apoptotic events in embryos undergoing apoptosis in
response to ionizing radiation.
*
This work was supported by the Howard Hughes Medical
Institute.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
An Associate of the Howard Hughes Medical Institute.
§
An Investigator of the Howard Hughes Medical Institute. To whom
correspondence should be addressed: Howard Hughes Medical Institute and
Dept. of Pharmacology, University of Colorado School of Medicine, 4200 E. Ninth Ave., Box C-236, Denver, CO 80262. Tel.: 303-315-7075; Fax:
303-315-7160; E-mail: Jim.Maller@uchsc.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Yu, J. Megyesi, and P. M. Price
Cytoplasmic initiation of cisplatin cytotoxicity
Am J Physiol Renal Physiol,
July 1, 2008;
295(1):
F44 - F52.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Fikaris, A. E. Lewis, A. Abulaiti, O. M. Tsygankova, and J. L. Meinkoth
Ras Triggers Ataxia-telangiectasia-mutated and Rad-3-related Activation and Apoptosis through Sustained Mitogenic Signaling
J. Biol. Chem.,
November 17, 2006;
281(46):
34759 - 34767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wallace and K. L. Ball
Docking-Dependent Regulation of the Rb Tumor Suppressor Protein by Cdk4
Mol. Cell. Biol.,
June 15, 2004;
24(12):
5606 - 5619.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|